FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound
· cnbc.com · popularity 39/100 · 0 similar stories today · Medicine & Clinical Health (Health & Life Sciences)
Read the original at cnbc.com →
Summary
The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes.
Found in: CNBC Top News. Rating basis: single outlet; outlet tier 5; 1 feeds; feed position 3.